With people right across Australia continuing to be impacted by bushfires, please know that Diabetes Australia is here to help if we can.
If you have any questions or concerns about any aspect of your diabetes management that has been impacted by bushfires you can call the NDSS Helpline on 1300 136 588 and talk to a trained health professional. Alternatively, you can email on ndss@diabetesaustralia.com.au
The Helpline is operating over the Christmas and New Years period.
Roche Diabetes Care have identified that Accu-Chek Aviva test strips, from LOT number 498287 only, may have a dosing issue.
The first New York City Marathon took place in 1970 and was held entirely in Central Park. There were just 127 entrants and only 55 of them finished. Fast forward to 2019, and the TCS New York Marathon has grown to become the world’s largest, with more than 50,000 national and international participants, including David Morgan running for Diabetes Australia, taking part in the 42.2 kilometre-long course through the heart of the Big Apple.
Product defect correction - risk of delayed therapy due to potential battery issues
Consumers and healthcare professionals are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters.
AMSL advises that a potential safety issue has been identified with A/C power adapters for Tandem t:slim X2 insulin pumps.
To celebrate World Diabetes Day 2019, we are giving away a $400 Mantra voucher for a My Diabetes Family Holiday to one lucky diabetes family!*
To be in the running to win, all you have to do is post a picture on social media and tell us who is in your diabetes family and why they are so important to you – make sure you tag them so that they can see how grateful you are for their support!
Up to one in four Australians with type 2 diabetes are reluctant to commence using insulin, even if it is recommended by their healthcare team.
Research has found many people with type 2 diabetes delay the commencement of insulin because of psychological factors including feelings of failure or negative thoughts about the progression of the disease.
A new class of diabetes drugs – SGLT 2 inhibitors could have a range of benefits for cardiovascular health.
With the support of a grant from the Diabetes Australia Research Trust Associate Professor Neale Cohen, from the Baker Heart and Diabetes Institute, is trying to find new therapies to improve the health of people with diabetes.
David Morgan is tackling the seven highest mountains on seven continents (and seven marathons for an extra challenge) to raise money for Diabetes Australia. Read his account of the ascent of Mt Elbrus, Europe's highest peak.
